Example: Heart Attack

Clinical Trials Sponsored by Institute of Tropical Medicine, University of Tuebingen

Total 12 results

NCT02450578

Completed

DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria

Conditions: Plasmodium Falciparum, Malaria
NCT03093129

Recruiting

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)

Conditions: Colorectal Cancer
NCT01624961

Completed

Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults

Conditions: Malaria
NCT03057756

Recruiting

Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance

Conditions: Multi-drug Resistant Tuberculosis
NCT02115516

Completed

Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis

Conditions: Malaria; Plasmodium Falciparum Malaria
NCT02237586

Completed

Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge

Conditions: Plasmodium Falciparum Malaria; Malaria
NCT00331136

Completed

Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

Conditions: Uncomplicated Plasmodium Falciparum Malaria
NCT02704533

Completed

Sequential Optimization of Dose and Schedule of PfSPZ Vaccine

Conditions: Malaria
NCT00811421

Completed

Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy

Conditions: Pregnancy; Malaria; HIV Infections
NCT02296983

Unknown status

A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Conditions: Ebola Virus Disease
NCT02287480

Completed

VSV-ZEBOV Geneva Vaccine Trial

Conditions: Ebolavirus Disease
NCT02283099

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

Conditions: Hemorrhagic Fever, Ebola